Evidence map›Paper›PMID 31832732›Full record

SynthesisEuropean journal of clinical pharmacology2020

Association between anticholinergic drug burden and mortality in older people: a systematic review.

Sheraz Ali, Gregory M Peterson, Luke R Bereznicki, Mohammed S Salahudeen

Abstract readMeta-AnalysisSystematic Review
PubMed Publisher
In one paragraph

Synthesis in European journal of clinical pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sheraz AliKing Saud Medical City, Ministry of Health, Riyadh, Saudi Arabia.ORCID https://orcid.org/0000-0001-9557-0345
Gregory M PetersonDiscipline of Pharmacy, School of Medicine, University of Tasmania, Hobart, 7005, Australia.ORCID https://orcid.org/0000-0002-6764-3882
Luke R BereznickiDiscipline of Pharmacy, School of Medicine, University of Tasmania, Hobart, 7005, Australia.ORCID https://orcid.org/0000-0003-3974-3437
Mohammed S SalahudeenDiscipline of Pharmacy, School of Medicine, University of Tasmania, Hobart, 7005, Australia. mohammed.salahudeen@utas.edu.au.ORCID https://orcid.org/0000-0001-9131-7465

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe purpose of the study is to conduct a systematic review of studies examining the association between anticholinergic burden and mortality in older individuals.

methodsA literature search was performed to identify relevant studies, using MEDLINE, EMBASE, PsycINFO and CENTRAL, from January 1990 to December 2018. We included studies of patients with a mean age of 65 years or older where the anticholinergic burden was estimated using anticholinergic risk assessment tools, and associations between anticholinergic load and mortality were investigated. The primary outcome of interest was the association between anticholinergic burden and mortality.

resultsTwenty-seven studies were included. These were three cross-sectional, one nested case-control and 23 prospective or retrospective cohort studies. Most studies were determined to be of good quality. A total of 15 studies reported a positive correlation between anticholinergic burden and mortality, while the remaining 10 studies did not report a significant association. Eighteen out of 27 studies (80%) had a short follow-up period of 1 year or less. Among the five high-quality studies that met all the domains of the quality assessment criteria, four showed a positive association.

conclusionThe variation in results could relate to the quality of the studies, follow-up period, anticholinergic risk assessment tool used and the study setting. Sixty-three percent (n = 17) of all the included studies, but almost all of the high-quality studies with an extended follow-up, reported a positive correlation between anticholinergic burden and mortality. Further high-quality research, using standardized measures and with adequate follow-up periods, is required to confirm the relationship between anticholinergic burden and mortality.

Indexed as

AgedCase-Control StudiesCause of DeathCholinergic AntagonistsCross-Sectional StudiesHumansMortalityProspective StudiesRetrospective StudiesCholinergic AntagonistsAnticholinergicAnticholinergic burdenMortalityOlder people

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.